Cisapride has 4 known drug interactions based on U.S. FDA drug labeling data. Of these, 3 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Itraconazole, Ketoconazole, Levoketoconazole. Patients taking Cisapride should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Contraindicated
- 3
- Moderate
- 1
Contraindicated (3)
- Cisapride + Itraconazole— Coadministration is contraindicated. Itraconazole increases plasma concentrations, potentially increasing pharmacologic …
- Cisapride + Ketoconazole— Ketoconazole increases cisapride plasma concentrations, potentially causing QT prolongation and life-threatening ventric…
- Cisapride + Levoketoconazole— Concomitant use is contraindicated due to increased risk of QT prolongation and torsades de pointes.
Moderate (1)
- Cisapride + Rapamycin— Weak/moderate CYP3A4/P-gp inhibitor that may increase sirolimus concentrations. Monitor and adjust dosage as needed.